VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Paracetamol ODT
Phase 1
Small molecule
H
HALEON
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Fever
1 trial
A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to Assess Bioequivalence With Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions
Completed
·
H
HALEON
·
Phase 1
·
NCT06855576
·
54 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Paracetamol ODT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Paracetamol ODT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Paracetamol ODT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
HALEON company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
H
HALEON
Related News